FYERS
Home
/
Stocks
/
Profit Loss
/
Sanofi India Profit & Loss

Sanofi India Profit & Loss

Consolidated
Standalone
Quarterly
Yearly
₹
%
Name
Net Revenue
Other Income
Total Revenue
Total Expenditure
Operating Profit
Interest Expense
PBT
Net Profit
Jun 2026Mar 2026Dec 2025Sep 2025Jun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022Jun 2022Mar 2022Dec 2021Sep 2021Jun 2021Mar 2021Dec 2020Sep 2020Jun 2020Mar 2020Dec 2019Sep 2019Jun 2019Mar 2019Dec 2018Sep 2018Jun 2018Mar 2018Dec 2017Sep 2017Jun 2017Mar 2017Dec 2016Sep 2016Jun 2016Mar 2016Dec 2015Sep 2015Jun 2015Mar 2015Dec 2014Sep 2014Jun 2014Mar 2014Dec 2013Sep 2013Jun 2013Mar 2013Dec 2012Sep 2012
₹438 Cr₹472 Cr₹420 Cr₹475 Cr₹406 Cr₹536 Cr₹515 Cr₹524 Cr₹464 Cr₹511 Cr₹469 Cr₹491 Cr₹515 Cr₹737 Cr₹672 Cr₹692 Cr₹699 Cr₹707 Cr₹688 Cr₹755 Cr₹789 Cr₹725 Cr₹720 Cr₹687 Cr₹711 Cr₹785 Cr₹826 Cr₹779 Cr₹748 Cr₹717 Cr₹726 Cr₹744 Cr₹684 Cr₹618 Cr₹670 Cr₹668 Cr₹601 Cr₹553 Cr₹605 Cr₹638 Cr₹620 Cr₹557 Cr₹569 Cr₹586 Cr₹550 Cr₹489 Cr₹512 Cr₹515 Cr₹506 Cr₹445 Cr₹488 Cr₹497 Cr₹435 Cr₹388 Cr₹423 Cr₹416 Cr
₹6 Cr₹4 Cr₹3 Cr₹5 Cr₹9 Cr₹3 Cr₹6 Cr₹2 Cr₹5 Cr₹4 Cr₹9 Cr₹11 Cr₹16 Cr₹26 Cr₹20 Cr₹11 Cr₹16 Cr₹24 Cr₹16 Cr₹15 Cr₹17 Cr₹26 Cr₹16 Cr₹15 Cr₹29 Cr₹30 Cr₹25 Cr₹23 Cr₹23 Cr₹23 Cr₹20 Cr₹26 Cr₹21 Cr₹23 Cr₹18 Cr₹21 Cr₹28 Cr₹16 Cr₹15 Cr₹15 Cr₹11 Cr₹26 Cr₹13 Cr₹9 Cr₹10 Cr₹19 Cr₹15 Cr₹14 Cr₹14 Cr₹22 Cr₹12 Cr₹15 Cr₹15 Cr₹16 Cr₹16 Cr₹8 Cr
₹444 Cr₹477 Cr₹423 Cr₹480 Cr₹415 Cr₹539 Cr₹521 Cr₹526 Cr₹468 Cr₹514 Cr₹479 Cr₹501 Cr₹530 Cr₹762 Cr₹692 Cr₹703 Cr₹715 Cr₹731 Cr₹704 Cr₹769 Cr₹806 Cr₹751 Cr₹737 Cr₹702 Cr₹740 Cr₹814 Cr₹851 Cr₹802 Cr₹771 Cr₹740 Cr₹747 Cr₹770 Cr₹704 Cr₹640 Cr₹689 Cr₹688 Cr₹629 Cr₹569 Cr₹620 Cr₹653 Cr₹631 Cr₹582 Cr₹581 Cr₹595 Cr₹560 Cr₹508 Cr₹527 Cr₹529 Cr₹519 Cr₹466 Cr₹500 Cr₹513 Cr₹450 Cr₹404 Cr₹439 Cr₹423 Cr
₹331 Cr₹339 Cr₹339 Cr₹350 Cr₹321 Cr₹374 Cr₹406 Cr₹413 Cr₹357 Cr₹383 Cr₹379 Cr₹386 Cr₹402 Cr₹516 Cr₹515 Cr₹520 Cr₹549 Cr₹523 Cr₹572 Cr₹570 Cr₹563 Cr₹556 Cr₹574 Cr₹515 Cr₹554 Cr₹629 Cr₹670 Cr₹630 Cr₹616 Cr₹590 Cr₹615 Cr₹583 Cr₹545 Cr₹509 Cr₹562 Cr₹510 Cr₹511 Cr₹477 Cr₹534 Cr₹519 Cr₹497 Cr₹454 Cr₹485 Cr₹473 Cr₹457 Cr₹432 Cr₹480 Cr₹435 Cr₹432 Cr₹388 Cr₹398 Cr₹396 Cr₹370 Cr₹338 Cr₹372 Cr₹347 Cr
₹122 Cr₹147 Cr₹93 Cr₹139 Cr₹104 Cr₹175 Cr₹124 Cr₹122 Cr₹121 Cr₹141 Cr₹109 Cr₹124 Cr₹137 Cr₹256 Cr₹187 Cr₹193 Cr₹177 Cr₹219 Cr₹144 Cr₹214 Cr₹264 Cr₹216 Cr₹183 Cr₹207 Cr₹206 Cr₹206 Cr₹203 Cr₹198 Cr₹181 Cr₹177 Cr₹157 Cr₹214 Cr₹185 Cr₹157 Cr₹153 Cr₹205 Cr₹144 Cr₹117 Cr₹124 Cr₹161 Cr₹161 Cr₹156 Cr₹126 Cr₹151 Cr₹131 Cr₹102 Cr₹71 Cr₹118 Cr₹111 Cr₹103 Cr₹126 Cr₹140 Cr₹102 Cr₹88 Cr₹89 Cr₹107 Cr
₹30 L₹30 L₹60 L₹40 L₹40 L₹30 L₹40 L₹40 L₹40 L₹30 L₹40 L₹30 L₹70 L₹30 L₹40 L₹50 L₹40 L₹40 L₹40 L₹50 L₹50 L₹40 L₹40 L₹40 L₹50 L₹50 L₹30 L₹0₹0₹0₹70 L₹0₹0₹0₹1 Cr₹0₹0₹40 L₹1 Cr₹30 L₹70 L₹10 L₹10 L₹10 L₹10 L₹10 L₹10 L₹0₹20 L₹20 L₹0₹0₹10 L₹30 L₹30 L₹30 L
₹112 Cr₹138 Cr₹83 Cr₹102 Cr₹94 Cr₹165 Cr₹122 Cr₹113 Cr₹92 Cr₹105 Cr₹99 Cr₹115 Cr₹127 Cr₹264 Cr₹190 Cr₹182 Cr₹166 Cr₹326 Cr₹132 Cr₹688 Cr₹243 Cr₹195 Cr₹170 Cr₹186 Cr₹187 Cr₹135 Cr₹161 Cr₹133 Cr₹155 Cr₹151 Cr₹131 Cr₹188 Cr₹160 Cr₹132 Cr₹126 Cr₹179 Cr₹118 Cr₹92 Cr₹85 Cr₹134 Cr₹133 Cr₹128 Cr₹96 Cr₹122 Cr₹103 Cr₹92 Cr₹47 Cr₹94 Cr₹87 Cr₹78 Cr₹127 Cr₹117 Cr₹79 Cr₹66 Cr₹66 Cr₹76 Cr
₹84 Cr₹103 Cr₹62 Cr₹76 Cr₹70 Cr₹120 Cr₹91 Cr₹82 Cr₹103 Cr₹137 Cr₹138 Cr₹152 Cr₹123 Cr₹190 Cr₹131 Cr₹131 Cr₹120 Cr₹238 Cr₹90 Cr₹530 Cr₹178 Cr₹146 Cr₹123 Cr₹133 Cr₹136 Cr₹85 Cr₹97 Cr₹127 Cr₹97 Cr₹93 Cr₹79 Cr₹119 Cr₹100 Cr₹83 Cr₹76 Cr₹116 Cr₹74 Cr₹60 Cr₹53 Cr₹83 Cr₹86 Cr₹83 Cr₹120 Cr₹73 Cr₹64 Cr₹65 Cr₹93 Cr₹62 Cr₹58 Cr₹52 Cr₹93 Cr₹77 Cr₹51 Cr₹44 Cr₹45 Cr₹51 Cr

Share Price Live Stats

Open (₹)2,940.00
Volume (₹)10,580.00
High (₹)2,995.50
Upper Circuit3,547.40
Low (₹)2,927.80
Lower Circuit2,365.00
Prev Close2,956.20
52W High (₹)4,898.00
Price2,981.70
52W Low (₹)2,907.40

Share Market Cap & Key Ratios Overview

M.Cap (₹)6819.94 Cr
Div. Yield (%)4.15
PE Ratio21.06
Debt to Equity0.00
Price to Book13.89
Book Value294.48
EPS (TTM)140.60
Face Value10.00
ROE (%)44.50

Stock Analysis (SWOT)

StrengthsWeaknessesOpportunitiesThreats
1. Premium insight available after login
2. Sign in to view full SWOT analysis
3. Unlock strengths, weaknesses, opportunities & threats
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

QVT

Quality
0/100-
Valuation
0/100-
Technical
0/100-
Sign in to view
Open a free Demat account in minutes to start investing and screening .
LoginSign Up

Peer Stocks

1 week
1 month
1 year
Name
SUNPHARMANSE
DIVISLABNSE
TORNTPHARMNSE
ZYDUSLIFENSE
LAURUSLABSNSE
CIPLANSE
DRREDDYNSE
MANKINDNSE
AUROPHARMANSE
LUPINNSE
SANOFINSE
LTP
1W Low
1W High
Market cap (₹)
1746.4-13.6 (-0.77%)
1725.50
1776.60
4,24,466Cr
9023-317 (-3.39%)
8937.50
9431.50
2,46,222Cr
4580-76.9 (-1.65%)
4551.80
4682
1,76,301Cr
1124.7+7.2 (0.64%)
1107.30
1150.90
1,12,818Cr
2036.9+0.3 (0.01%)
2007.80
2069.20
1,10,823Cr
1314.6+13.6 (1.05%)
1300.20
1333.30
1,07,447Cr
1216+19 (1.59%)
1196.90
1250.70
1,03,471Cr
2335-33.5 (-1.41%)
2317.50
2426.80
97,850Cr
1662.9-30.1 (-1.78%)
1654.10
1715
96,836Cr
1953.2-3.3 (-0.17%)
1925.70
1964.90
89,629Cr
2981.7+36.3 (1.23%)
2907.40
2995.50
6,820Cr
Empty box

No content available